Takeda Pharmaceutical are launching an open innovation initiative, inviting researchers to submit their ideas and technologies across five different focus areas, up to £60k / €70k / $100k (AUD). Summarised below are the interests of Takeda relating to Novel Targets and Treatments in Immunology and Rare Diseases. In the attached application form, each of these topics have been expanded upon to give further detail of proposals.
Submissions should be relevant to one or more of the following titles:
- REF #8 Regulatory immune cell-focused research applicable...